1. Integrative analyses of RNA-seq and ChIP-seq Reveal MITF as a Target Gene of TFPI-2 in MDA231 Cells
   Guangli Wang et al, 2023, Biochemical Genetics CrossRef
2. The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system
   Hiroshi Kobayashi et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
3. Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors
   Hiroshi Kobayashi et al, 2022, Journal of Obstetrics and Gynaecology Research CrossRef
4. Tissue factor pathway inhibitor 2: Current understanding, challenges, and future perspectives
   Hiroshi Kobayashi et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
5. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma
   Lizhi Pang et al, 2023, Nature Immunology CrossRef
6. Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin
   Shiro Koizume et al, 2023, Cancer Science CrossRef
7. Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study
   Ryuji Kawaguchi et al, 2024, International Journal of Gynecological Pathology CrossRef
8. Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia
   Hiroshi Kobayashi et al, 2023, Biomedicines CrossRef
9. Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer
   Ryuji Kawaguchi et al, 2023, Oncology Letters CrossRef
10. Toward an understanding of tissue factor pathway inhibitor‐2 as a novel serodiagnostic marker for clear cell carcinoma of the ovary
    Hiroshi Kobayashi et al, 2021, Journal of Obstetrics and Gynaecology Research CrossRef